Pramipexole for hard-to-treat OCD
Treatments studied
Part of Mental health clinical trials.
This study tests if pramipexole can help people whose OCD hasn't improved with standard treatments like SSRIs or certain antipsychotics. You might qualify if standard therapies haven't worked for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old
- Your native language is European Portuguese
- You have been diagnosed with obsessive-compulsive disorder (OCD)
- You have tried at least two different SSRIs (antidepressants) at a high enough dose for 12 weeks and they did not help enough
- You have also tried risperidone or aripiprazole with an SSRI for 12 weeks and still have moderate to severe OCD symptoms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if valbenazine, a medication that affects brain chemicals, can reduce OCD symptoms in adults. Participants must have moderate to severe OCD and take the pill daily for the study period.
This trial tests whether a gentle brain stimulation (tDCS) combined with facing your fears can help people with hard-to-treat OCD. If you've tried multiple treatments without relief, this study may offer a new option.
This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.
This trial is testing a brain implant that sends electrical signals to specific areas of the brain to help people with very severe obsessive-compulsive disorder (OCD) that has not improved with other treatments. The goal is to see if this treatment can reduce OCD symptoms and improve daily functioning.
This trial tests a non-invasive brain stimulation technique called tDCS (which uses a mild electrical current on the scalp) to see if it can reduce OCD symptoms. It is for people whose OCD has not improved with standard treatments.
This study tests whether a drug called psilocybin (the active ingredient in 'magic mushrooms') can help people with obsessive-compulsive disorder (OCD) who haven't found relief from standard treatments. It involves a few sessions with the drug under supervision, along with MRI scans and follow-up visits.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.